Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for Immunocore Holdings (IMCR) over the last 3 years, with Q3 2025 value amounting to $50.4 million.

  • Immunocore Holdings' Shares Outstanding (Weighted Average) rose 76.32% to $50.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.4 million, marking a year-over-year increase of 76.32%. This contributed to the annual value of $50.0 million for FY2024, which is 225.43% up from last year.
  • As of Q3 2025, Immunocore Holdings' Shares Outstanding (Weighted Average) stood at $50.4 million, which was up 76.32% from $50.3 million recorded in Q2 2025.
  • Immunocore Holdings' Shares Outstanding (Weighted Average)'s 5-year high stood at $50.4 million during Q3 2025, with a 5-year trough of $50.0 in Q3 2023.
  • Over the past 3 years, Immunocore Holdings' median Shares Outstanding (Weighted Average) value was $50.0 million (recorded in 2024), while the average stood at $44.4 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first skyrocketed by 10004377800.0% in 2024, then surged by 42.0% in 2025.
  • Immunocore Holdings' Shares Outstanding (Weighted Average) (Quarter) stood at $48.9 million in 2023, then grew by 2.25% to $50.0 million in 2024, then rose by 0.83% to $50.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $50.4 million for Q3 2025, versus $50.3 million for Q2 2025 and $50.1 million for Q1 2025.